VanEck AA-BB級CLO主動型ETF CLOB 深 滬
已收盤 05-08 16:00:00 美东时间
50.5002
+0.040
+0.08%
華盛通- 最 高50.5745
- 今 開50.33
- 成交量 4886股
- 最 低 50.33
- 昨 收 50.4603
- 總市值 1.67亿
- 52周最高 50.70
- 市盈率 靜 --
- 換手率 0.15%
- 52周最低 47.0945
- 委 比 -60.00%
- 總股本 330.00万
- 歷史最高 50.5745
- 量 比 0.36
- 振 幅 0.48%
- 歷史最低 41.4462
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BGC Q1 FY26 GAAP net income climbs 52.7% to USD 80.7 million; revenue rises 43.8% to USD 955.5 million
BGC Q1 FY26 GAAP net income climbs 52.7% to USD 80.7 million; revenue rises 43.8% to USD 955.5 million BGC Group posted Q1 2026 net income for fully diluted shares of USD 80.7 million, up 52.7%, as revenue climbed 43.8% to USD 955.5 million. GAAP operating income before taxes rose 44.3% to USD 115.4
05-07 19:59
CME Group Introduces U.S. Dollar RepoFunds Rate
CME Group, the world's leading derivatives marketplace, today announced it has launched the U.S. dollar RepoFunds Rate (RFR USD) to provide a robust measure of overnight funding costs in U.S. repo markets.The new
05-06 23:12
VanEck Enters CLO Equity Market with First Interval Fund, Sub-advised by PineBridge
Actively managed by PineBridge Investments, the VanEck CLO Opportunities Fund seeks high income and attractive total return through exposure to CLO equity and junior mezzanine debt, building...
05-01 20:00
GLOBAL MARKETS-Stocks sink, oil leaps back towards $110 as Trump vows to keep hitting Iran
GLOBAL MARKETS-Stocks sink, oil leaps back towards $110 as Trump vows to keep hitting Iran Hopes of end to conflict evaporate after Trump speech Oil surges as stagflation risks swirl, denting risk assets Stocks sharply lower as Trump speech provides little clarity Investors likely to stay defensive
04-02 17:43
BRIEF-Formosa Pharmaceuticals Announces Licensing Agreement With Rxilient
Dec 3 (Reuters) - Formosa Pharmaceuticals Inc 6838.TW: FORMOSA PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH RXILIENT, FOR COMMERCIALIZATION OF CLOBETASOL PROPIONATE OPHTHALMIC SUSPENSION FOR THE...
2025-12-03 20:39
BRIEF-Harrow Acquires U.S. Commercial Rights To Byqlovi™ From Formosa Pharmaceuticals
June 9 (Reuters) - Formosa Pharmaceuticals Inc 6838.TW: HARROW ACQUIRES U.S. COMMERCIAL RIGHTS TO BYQLOVI™ (CLOBETASOL PROPIONATE OPHTHALMIC SUSPENSION) 0.05% FROM FORMOSA PHARMACEUTICALS HARROW: HARR...
2025-06-09 19:19
